[Expert Solution]: 150 of 150 When considering the use of the…

150 of 150 When considering the use of the NMDA receptor antagonist memantine for a patient with Alzheimer’s dementia, the PMHNP realizes all of the following are true except: This agent is typically used following cholinesterase inhibitor therapy. Adverse effects include dizziness, agitation, and confusion. Its use is angonality. This agent is to severe Alzheimer’s dementia. 64% reeli coller Now Search